Corporate Contributors News

Meet CooperVision’s 2017 Best Practices Honorees

Meet CooperVision’s 2017 Best Practices Honorees

New Class Chosen for Their Leadership and Success in Optometry From small practices to large practices. From a broad array of services to the specialized. From “tried and true” to the completely unexpected. Despite their differences, 10 remarkable US eye care practices have much in common. They have forged new pathways to success in the […]

CooperVision Begins Rollout of Avaira Vitality™ toric

CooperVision Begins Rollout of Avaira Vitality™ toric

State-of-the-Art Silicone Hydrogel Material Provides High Oxygen Transmissibility to Wearers with Astigmatism. The latest advancements in two-week contact lens technology are now available to eye care professionals and their astigmatic patients, as CooperVision, Inc. announced today the beginning of its limited rollout of Avaira Vitality™ toric. The lens is the latest addition to the new […]

LensFerry® S Expands to Include All Contact Lens Modalities

LensFerry® S Expands to Include All Contact Lens Modalities

Doctor-Friendly Subscription Service Promotes Increased Annual Supply Sales for Practices and Convenience for WearersEyeCare Prime® announced that LensFerry® S has expanded to include all modalities, bringing the convenience of automatic monthly payments and quarterly or semi-annual contact lens deliveries to a broader spectrum of patients while maintaining a central role for the eye care professional. The […]

Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Bausch + Lomb And Nicox Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod

Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, and Nicox S.A. (Euronext Paris: FR0013018124, COX) announced that the US Food and Drug Administration (FDA) has set a PDUFA date of August 24, 2017 for its decision on the New Drug Application (NDA) for latanoprostene bunod ophthalmic solution, 0.024%. Latanoprostene […]

Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses

Bausch + Lomb Introduces Biotrue® ONEday for Astigmatism Contact Lenses

New Innovative Daily Disposable Lens Designed to Provide Astigmatic Patients Consistently Clear Vision and Comfort Throughout the Day. Baush + Lomb, a leading global eye health company, announced the introduction of Biotrue® ONEday for Astigmatism daily disposable contact lenses. Approximately 73.2 million people in the US are astigmatic, but only 8. million people are currently […]

New Data Show Contact Lenses Feel Like New After Using CLEAR CARE® PLUS with HydraGlyde

New Data Show Contact Lenses Feel Like New After Using CLEAR CARE® PLUS with HydraGlyde

Alcon, the global leader in eye care and a division of Novartis, announced today the results of its Bubble Upgrade Challenge survey that shows 81 percent (81%) of patients surveyed agreed that their lenses felt like new after using CLEAR CARE® PLUS with HydraGlyde hydrogen peroxide-based cleaning and disinfecting solution, as compared to 24 percent […]

Alcon Launches New Digital Vision Care Marketing Portal for Eye Care Professionals

Alcon Launches New Digital Vision Care Marketing Portal for Eye Care Professionals

Alcon, the global leader in eye care and a division of Novartis, announced the launch of a comprehensive marketing portal with digital resources and content to help Eye Care Professionals (ECPs) strengthen their  online outreach to patients. Located on alconODmarketing.com, the Alcon Vision Care Marketing Portal (the Portal) offers e-Marketing tools and training as well […]